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Purpose: One approach to identify genes that contribute to common complex ocular disorders such as primary open angle
glaucoma (POAG) is to study the genetic determinates of endophenotypes that are defined by underlying pre-disposing
heritable quantitative traits such as central corneal thickness (CCT). Collagen VIII is a major component of Descemet’s
membrane and studies in mice have indicated that targeted inactivation of the genes encoding the collagen type 8 alpha1
(Col8a1) and collagen type 8 alpha2 (Col8a2) subunits (COL8A1 and COL8A2) results in thinning of the corneal stroma
and of Descemet’s membrane. The purpose of this study is to evaluate COL8A1 and COL8A2 as candidate genes for thin
CCT in human POAG patients.
Methods: 100 Caucasian POAG patients were enrolled in this study. The entire COL8A1 and COL8A2 coding sequence
was determined in 8 patients with CCT<513 µm (one standard deviation (36 microns) below the mean (550 microns) and
8 patients with CCT>586 µm (one standard deviation above the mean). Selected COL8A2 exons containing variants of
interest were sequenced in the full POAG cohort. Association and quantitative trait analyses were performed.
Results: Three patients with CCT less than 513 µm and advanced POAG were found to have missense changes in
COL8A2; two patients had a previously identified mutation, R155Q and one had a novel change, P678L (p=0.0035, Fisher’s
exact test). Missense changes were not found in any of the patients with CCT>513 µm and missense changes in the
COL8A1 gene were not found in any patient. One common COL8A2 SNP, rs274754 was also statistically associated with
CCT (p=0.018).
Conclusions: In this study we have identified COL8A2 missense changes in a group of Caucasian patients with very thin
CCT and advanced POAG. These results suggest that DNA sequence variants in the COL8A2 gene may be associated
with thin corneas in some glaucoma patients. Further study of COL8A2 variants in other patient populations, especially
those with thinner CCT such as African-Americans would provide further support for a role of COL8A2 in corneal
thickness and in glaucoma.
Primary open angle glaucoma (POAG) is phenotypically
and genetically complex. One approach to identify genes that
contribute to common complex traits is to study the genetic
determinants  of  endophenotypes  that  are  defined  by
underlying  pre-disposing  quantitative  traits  [1].  Mapping
genes influencing the related quantitative trait, rather than the
complete  complex  phenotype,  has  several  important
advantages including objective phenotype definitions and a
possible reduction in the underlying molecular heterogeneity.
Several  quantitative  traits  with  significant  heritability  are
associated with POAG including intraocular pressure (IOP),
optic nerve vertical cup-to-disc ratio, optic nerve area, and
central corneal thickness (CCT) [2-9].
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The ocular hypertension treatment trial (OHTS) initially
identified thin CCT as a risk factor for progression from ocular
hypertension to glaucoma [10]. Subsequently, other studies
have suggested that thin CCT is associated with increased
severity of visual field loss and more rapid progression of
visual  field  loss  [11-15].  Central  corneal  thickness  is  a
normally  distributed,  highly  heritable  quantitative  trait  in
human  populations  [16],  with  individuals  of  African  race
having lower CCT than Caucasian populations [17,18]. The
increased  incidence  of  POAG  in  African  populations  is
consistent with the increased risk of disease associated with
thin CCT.
Candidate  gene  studies  and  a  recent  genome-wide
association  study  have  identified  several  genes  that  may
contribute to CCT variation, including the genes for type I
collagen [19] and the genes coding for collagen 5 alpha1
(COL5A1),  autogenous  vein  graft  remodeling  associated
protein  8  (AVGR8),  and  A-kinase  anchor  protein  13
(AKAP13) [20]. These results suggest that genes coding for
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2185proteins that maintain corneal stromal integrity may be good
candidates for genetic determinants influencing the trait.
Collagen  VIII  (COL8)  is  a  major  component  of
Descemet’s membrane, and is composed of two subunits,
collagen VIIIA1 (COL8A1) and collagen VIIIA2 (COL8A2)
which form homotrimers [21]. Targeted inactivation of the
COL8A1  and  COL8A2  genes  in  mice  results  in  anterior
segment dysgenesis and thin corneal stroma [22], suggesting
that  COL8A1  and/or  COL8A2  may  contribute  to  the
development  of  thin  CCT.  Further  support  for  a  role  of
COL8A2 in corneal thickness comes from a more recent study
documenting thin corneas in mice with a COL8A2 missense
change, G257D [23]. The purpose of this study is to evaluate
COL8A1 and COL8A2 as candidate genes for thin CCT in
human POAG patients.
METHODS
Patients: This study was approved by the institutional review
board of the Massachusetts Eye and Ear Infirmary, Boston,
MA. After informed consent, 100 Caucasian POAG patients
from  the  Massachusetts  Eye  and  Ear  Infirmary  glaucoma
service were enrolled in this study. Central corneal thickness
(CCT) was measured using an ultrasonic pachymeter (DGH
Technology, Inc., Exton, PA). The recorded value was an
average of three measurements for each eye. The number used
for CCT for each patient was the average of each eye. The
following  criteria  were  used  to  establish  POAG  affected
status: 1) IOP≥22 mmHg in both eyes on 2 occasions, or
IOP≥19 mmHg in both eyes on treatment with 2 or more
glaucoma medications; 2) Visual field loss in at least one eye
on a reliable visual field (reliable visual field is defined by
fixation  loss  ≤33%,  false  positive  rate  ≤20%  and  false
negative rate ≤20%) that is in a distribution consistent with
nerve fiber layer loss and corresponds to changes in the optic
nerve;  and  3)  Optic  nerve  damage  in  at  least  one  eye
characterized by two of the following: vertical cup/disc ratio
>0.7, superior or inferior neuroretinal rim <0.1, focal notching
of the superior or inferior neuroretinal rim, nerve fiber bundle
defect with a width of 2 or more retinal vein diameters located
1 disc diameter from the optic nerve, asymmetry of the cup/
disc  ratio  >0.2  without  asymmetric  refraction,  and  disc
hemorrhage. Patients with known corneal disease and patients
who  had  undergone  corneal  surgery,  including  refractive
surgery, were excluded from this study.
DNA sequencing: Genomic DNA was prepared from buccal
cell  samples  using  established  techniques  (Gentra,
Minneapolis,  MN).  Initially,  the  entire  coding  region  of
COL8A1  and  COL8A2  was  sequenced  in  8  patients  with
CCT<513  μm  (one  standard  deviation  from  the  mean  of
550±36 μm) and 8 patients with CCT>586 μm (one standard
deviation from the mean). Genomic DNA was sequenced
using primers (Table 1) designed to amplify the coding exons
as well as the adjacent splice sites for both the COL8A1 and
COL8A2 genes.  PCR was performed in a thermal cycler
(model 2720; Applied Biosystems Inc., Foster City, CA) set
at the following parameters: 50 °C for 2 min, 95 °C for 10 min,
TABLE 1. CHARACTERISTICS OF PRIMERS USED FOR AMPLIFICATION AND SEQUENCING.
Primer name Sequence Melting temp Product size
Primers for coding exons of COL8A1 (NM_001850)  
Exon 4 Forward AAGTCACTTGGCCTTGCAG 59.02 456
Exon 4 Reverse CCCCTCTGATCCCATAATTTAG 58.84  
Exon 5_1 Forward ACTTCATTGATGTGAGAGACAATC 57.34 630
Exon 5_1 Reverse TGGAGCCCCTGGCTTTC 62.33  
Exon 5_2 Forward AGGTGCGCCAGGTGTAAAG 61.24 594
Exon 5_2 Reverse ACTTCACCAAGGAAACCTGG 59.04  
Exon 5_3 Forward CAAAGGAGAAGGTGGGATTG 59.52 584
Exon 5_3 Reverse TGCCTTTCTTAGCCCCGTAG 61.59  
Exon 5_4 Forward GAGTGGCAGGACTTCATGG 59.20 777
Exon 5_4 Reverse TGTACACAATGGTCCAAATTTTC 58.78  
Primers for coding exons of COL8A2 (NM_005202)  
Exon 1 Forward CAGGGCTGGCTTGATGAC 60.36 312
Exon 1 Reverse AGGGAGGCAGGGGATTTG 62.33  
Exon 2_1 Forward GGAATGGGTAGATGGGGTC 59.01 599
Exon 2_1 Reverse AACCAGGTTTGCCTAAGCC 59.18  
Exon 2_2 Forward GATAATGGAGTGGGCCAGC 60.44 580
Exon 2_2 Reverse CACTAGGCCCCTGGTCAC 59.05  
Exon 2_3 Forward GCTTCCTGGCAGACGTG 59.00 597
Exon 2_3 Reverse AGCCCAAACTGTGGCTTG 59.83  
Exon 2_4 Forward CTCCCCTGGAATCACGG 59.98 636
Exon 2_4 Reverse TTGAAAAGGTCGCTCTACCAC 59.37  
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PCR products were directly sequenced on the ABI PRISM
3100 Genetic Analyzer (Applied Biosystems) with BigDye
Terminators  (Applied  Biosystems)  according  to  standard
protocols.  Selected  COL8A2  exons  containing  variants  of
interest were sequenced in the entire POAG cohort using the
same techniques.
Statistical methods: The association of missense changes in
COL8A2 and CCT<513 µm was assessed using Fisher’s exact
test. Quantitative trait analysis for rs274754 and rs3738360
was performed using PLINK (version 1.07) [24], and p-values
were adjusted for gender and age of enrollment using logistic
regression.
RESULTS
Identification of sequence variants in COL8A1 and COL8A2:
100  Caucasian  POAG  patients  with  a  mean  CCT  of
550±36 µm (range 488–676 µm) were evaluated for this study.
The  mean  CCT  in  our  POAG  sample  is  similar  to  that
observed in the normal Caucasian population [25]. The mean
age at enrollment was 68 years and the population was 51%
female. Initially we sequenced the entire coding sequence for
both  the  COL8A1  and  COL8A2  genes  in  8  patients  with
CCT<513 µm (one standard deviation from the mean) and in
8 patients with CCT>586 µm (one standard deviation from
the mean). Three patients with CCT less than 513 µm were
found to have missense changes in COL8A2; two patients had
a previously identified mutation, R155Q and one had a novel
change, P678L. Missense changes were not found in any of
the patients with CCT>586 µm and missense changes were
not found in any patients in the COL8A1 gene. Two common
COL8A2 SNPs, rs274754 and rs3738360 were also found in
both  groups  of  patients.  The  entire  cohort  was  further
genotyped for R155Q, P678L, rs274754, and rs3738360 by
genomic sequencing. Missense changes were not identified in
any of the remaining POAG patients. The location of each
variant in the COL8A2 gene is shown in Figure 1.
Quantitative trait analysis: The two common COL8A2 SNPs
(rs274754 and rs3738360) were genotyped in the entire cohort
and  analyzed  for  association  with  CCT.  The  genotype
frequencies,  mean  CCT  values  for  each  genotype  and
associated p values for these two SNPs are shown in Table 2.
SNP  rs274754,  located  in  the  first  intron  is  statistically
associated  with  CCT  (p=0.018),  while  SNP  rs3738360,
located in the 3′ UTR does not demonstrate an association in
this group of individuals.
COL8A2  missense  carrier  phenotypes:  Phenotypic
information for the three COL8A2 missense carriers is shown
Figure 1. Structure of the COL8A2 gene and protein domains. The COL8A2 gene consists of two exons separated by single intron. The protein
contains NC2, NC1, C1q, and triple helical domains as indicated. The locations of the variants studied are indicated with arrows.
TABLE 2. QTL ASSOCIATION ANALYSIS OF COMMON SNPS AND CCT IN CAUCASIAN POAG PATIENTS.
SNP Genotype N CCT µm (mean±SD)
rs3738360 TT 78 550.6±38.0
  GT 14 545.5±30.9
  GG 0 -
  Total 92 p-trend=0.64; p-adj=0.57
rs274754 TT 45 561.3±32.4
  CT 23 539.9±30.4
  CC 18 545.1±48.8
  Total 86 p-trend=0.047; p-adj=0.018
         CCT: the average measures of central corneal thickness between left and right eyes; p-adj: p value adjusting for sex and age of
         enrollment.
Molecular Vision 2010; 16:2185-2191 <http://www.molvis.org/molvis/v16/a234> © 2010 Molecular Vision
2187in  Table  3.  All  three  patients  have  very  thin  CCT,  and
advanced  POAG  including  elevated  intraocular  pressure,
optic nerve degeneration, and significant visual field defects.
None of these patients had undergone refractive surgery or
any other type of corneal surgery before CCT measurement.
Functional  significance  of  COL8A2  missense  variants:
R155Q  and  P678L  were  found  in  3  of  16  patients  with
CCT<513 µm and in none of the patients with CCT>513 µm
(p=0.0035, Fisher’s exact test). Both R155Q and P678L are
evolutionarily conserved amino acids (Figure 2). R155Q has
been previously defined as a pathological variant contributing
to Fuch’s Endothelial Dystrophy (FED) [26]. To further assess
the probability that these variants impact corneal pathogenesis
we used three tests of functional significance: PolyPhen-2
[27],  SIFT  [28]  and  PMUT  [29].  Both  PolyPhen-2  and
PMUT identified P678L as a pathological variant (Table 4),
while SIFT indicated that the proline to leucine change at
position 678 could be tolerated. Surprisingly, both PMUT and
SIFT suggested that R155Q, previously implicated in FED
and PPMD, could be a tolerated variant while PolyPhen-2 was
not able to make an assessment.
DISCUSSION
In this study we have identified COL8A2 missense changes in
a  group  of  Caucasian  patients  with  very  thin  CCT  and
advanced  POAG.  R155Q  was  found  in  two  patients  and
P678L was found in one patient with CCT<513 µm. Both of
these missense changes are evolutionarily conserved and are
likely to be pathogenic. R155Q is located in the evolutionarily
conserved triple helical domain. Although tests of functional
significance suggest that the glutamine could be tolerated at
position  155,  the  R155Q  change  has  been  previously
associated  with  Fuch’s  endothelial  dystrophy  (FED)  [26]
suggesting that the variant has a role in corneal disease. P678L
Figure 2. Evolutionary conservation of R155Q and P678L. Arrows
indicate the position of Arginine 155 and Proline 678. Conserved
amino acids are highlighted in yellow.
TABLE 3. COL8A2 MISSENSE CARRIER PHENOTYPES.
  Patient ID (genotype)
Phenotype information 4381 (R155Q) 4964 (R155Q) 4995 (P678L)
Gender Male Male Male
CCT µm (OD, OS) 502, 526 484, 481 507, 497
Age of enrollment 49 86 73
Visual acuity (OD, OS) 20/25, 20/50 20/60, 20/30 20/25, 20/20
Refractive error (OD, OS) -1.00 -0.75 x002
-1.50 -1.25 x017
-1.75 -1.26 x065
0.00 -2.25 x098
-0.50 -0.50 x150
0.00 -0.50 x047
Gonioscopy Open angle Open angle Open Angle
IOP >21 Yes Unknown Yes
Optic nerve VCDR (OD, OS) 0.95, 0.95 0.95, 0.90 0.9, 0.8
Visual Fields* OD: PSD 11.5- NS (S/I), ND (S/I),
PS (S)
OS: PSD 9.1- NS (S/I), ND (S/I),
PS (S/I)
OD: Central island only
OS: Central island only
OD: PSD 9.5- NS (S/I), ND (S/I),
PS (S/I)
OS: PSD 5.5- ND (S), PS (S/I)
        *Humphrey automated visual fields (24–2) were obtained for individuals 4831, 4995, and Goldman visual fields were available
        for individual 4964. Abbreviations: VCDR- vertical cup to disc ratio; PSD- pattern standard deviation; NS- Nasal step; ND-
        Nasal depression; PS- paracentral scotoma; S- superior; I- inferior.
TABLE 4. TESTS OF FUNCTIONAL SIGNIFICANCE.
SNP PolyPhen-2 PMUT SIFT
R155Q Unable to assess Neutral (score=0.439) Tolerated
P678L Probably damaging (score=0.999) Pathological (score=0.845) Tolerated
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highly conserved C1q domain. This variant is predicted to be
pathologic  by  PolyPhen-2  and  PMUT.  Other  COL8A2
missense  changes  have  also  been  found  in  FED  (R34H,
R304Q, Q455K, Q455V, and L450W) [26,30-33]. COL8A2
mutations have not been found in patients with keratoconus
or  keratoglobus  [34].  Our  patients  did  not  have  clinical
evidence of any of these corneal disorders.
As  the  previous  reports  relating  COL8A2  missense
changes  to  corneal  disease  have  not  included  CCT
measurement  as  part  of  the  clinical  assessment,  it  is  not
possible  to  determine  if  the  patients  carrying  these  gene
variants also had thin CCT. However, given our results and
the complex genetics of FED [35], it is likely that COL8A2
missense  changes  are  responsible  for  thin  CCT  and  that
COL8A2 variants may also be one factor that can contribute
to  FED.  Indeed  several  reports  support  this  hypothesis,
including a report describing familial aggregation, but not
perfect segregation, of a COL8A2 missense change and FED
[36] and the identification of the R155Q change in one FED
affected patient and two controls in a population from South
India [37]. The R155Q variant is also relatively common in
the Japanese, a population known to have thinner CCT [38,
39].
We also evaluated two common SNPs, rs274754 located
within intron 1 near the 5′ end of the gene and rs3738360
located in the 3′UTR. Only SNP rs274754 was statistically
associated with CCT, with the G allele associated with thinner
CCT. Interestingly the G allele of rs274754 is more common
in Africans (dbSNP), and individuals of African origin have
thinner  corneas  and  a  higher  incidence  of  POAG  than
Caucasians [40,41]. It would be of interest to evaluate the
association between CCT and rs274754 and other common
COL8A2 SNPs in a larger POAG sample and also in African
populations.
POAG is inherited as a complex non-Mendelian trait that
is likely to result from multiple genetic and environmental
factors.  Identifying  genes  responsible  for  POAG  pre-
disposing endophenotypes, such as thin CCT, is one path
toward defining the underlying complex genetic architecture
of the disease. This study suggests that COL8A2 gene variants
can contribute to thin CCT. Further studies identifying genes
that contribute to POAG endophenotypes will help define the
molecular events underlying the complex phenotype as well
as lead to gene-based tests for screening and diagnosis.
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